A new study from the University of Pittsburgh shows for the first time how exercise improves cancer outcomes and enhances ...

Acute myeloid leukemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making immediate treatment essential. While chemotherapy and targeted drugs have ...

June brought major blood cancer updates, and CURE is sharing the latest in myelofibrosis treatment and FDA breakthroughs, as well as survivorship news.

Welcome to the second installment of "Cancer and the Gut Microbiome: A Miniseries". Here, we focus on how the microbiome influences the effectiveness of cancer treatments, particularly immunotherapy ...

A routine blood test may be able to detect cancer more than three years before diagnosis, a new study suggests.

Announcing a new article publication for BIO Integration journal. Imbalances in the intestinal microbiome are closely ...

Given (1) the increased incidence of thromboembolic events in cancer, (2) the morbidity and mortality implications of thromboembolism in cancer, and (3) the under-reporting of thromboembolism in ...

The FDA has eliminated a safety monitoring requirement and eased certain restrictions that had been in place since CAR T-therapies first reached the market in 2017. The agency and financial ...

Restricted availability under an FDA-mandated drug safety program has limited the reach of CAR-T cell therapies for certain blood cancers—until now. | The FDA has removed the REMS requirements ...